Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Dec;55(12):870–874. doi: 10.1136/ard.55.12.870

Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: the Chingford study.

M E Lloyd 1, D J Hart 1, D Nandra 1, T E McAlindon 1, M Wheeler 1, D V Doyle 1, T D Spector 1
PMCID: PMC1010336  PMID: 9014579

Abstract

OBJECTIVE: To assess the association between serum insulin-like growth factor-I (IGF-1) concentrations and osteoarthritis, and bone mineral density, and fractures in a large group of middle aged women from the general population. METHODS: 761 women aged 44-64 years from the Chingford study had serum IGF-I concentrations measured; hand, hip, spine, and anteroposterior weight bearing knee radiographs taken; and dual energy x ray absorptiometry (DEXA) scans of the hip and spine. X rays were scored using the Kellgren and Lawrence system. In addition knee x rays were scored using a standard atlas for individual features of osteophytes and joint space narrowing (both graded 0-3). IGF-I concentrations were adjusted for the effects of age. RESULTS: In the osteoarthritis analysis results were compared to a constant group of 155 subjects with no evidence of osteoarthritis at any site. There was no significant difference in serum IGF-I between these subjects and 606 subjects with osteoarthritis at any site. When individual sites were analysed, serum IGF-I was higher in those cases with more severe bilateral knee osteoarthritis and in those with distal interphalangeal (DIP) joint disease. There was no significant association between serum IGF-I and other forms of osteoarthritis or milder forms of knee osteoarthritis. There was no correlation between IGF-I concentrations and bone mineral density at the spine or hip, nor any difference between IGF-I concentrations in subjects with and without a history of non-traumatic fracture [22.8 (SD 6.6) v 23.1 (SD 6.6) nmol litre-1, P = 0.6] CONCLUSIONS: There is a modest association between IGF-I concentrations and the development of DIP osteoarthritis and more severe or bilateral knee joint osteoarthritis in women from the normal population, but no association with other forms of osteoarthritis, bone density, or fractures.

Full text

PDF
870

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson S. B., Weissmann G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1989 Jan;32(1):1–9. doi: 10.1002/anr.1780320102. [DOI] [PubMed] [Google Scholar]
  2. Bagge E., Edén S., Rosén T., Bengtsson B. A. The prevalence of radiographic osteoarthritis is low in elderly patients with growth hormone deficiency. Acta Endocrinol (Copenh) 1993 Oct;129(4):296–300. doi: 10.1530/acta.0.1290296. [DOI] [PubMed] [Google Scholar]
  3. Bennett A. E., Wahner H. W., Riggs B. L., Hintz R. L. Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab. 1984 Oct;59(4):701–704. doi: 10.1210/jcem-59-4-701. [DOI] [PubMed] [Google Scholar]
  4. Degerblad M., Elgindy N., Hall K., Sjöberg H. E., Thorén M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh) 1992 May;126(5):387–393. doi: 10.1530/acta.0.1260387. [DOI] [PubMed] [Google Scholar]
  5. Denko C. W., Boja B., Moskowitz R. W. Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone. J Rheumatol. 1990 Sep;17(9):1217–1221. [PubMed] [Google Scholar]
  6. Dequeker J., Mohan S., Finkelman R. D., Aerssens J., Baylink D. J. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum. 1993 Dec;36(12):1702–1708. doi: 10.1002/art.1780361209. [DOI] [PubMed] [Google Scholar]
  7. Florini J. R. Hormonal control of muscle growth. Muscle Nerve. 1987 Sep;10(7):577–598. doi: 10.1002/mus.880100702. [DOI] [PubMed] [Google Scholar]
  8. Froesch E. R., Schmid C., Schwander J., Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol. 1985;47:443–467. doi: 10.1146/annurev.ph.47.030185.002303. [DOI] [PubMed] [Google Scholar]
  9. Hart D. J., Spector T. D. The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study. J Rheumatol. 1993 Feb;20(2):331–335. [PubMed] [Google Scholar]
  10. Johansson A. G., Burman P., Westermark K., Ljunghall S. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med. 1992 Nov;232(5):447–452. doi: 10.1111/j.1365-2796.1992.tb00613.x. [DOI] [PubMed] [Google Scholar]
  11. Kelly P. J., Eisman J. A., Stuart M. C., Pocock N. A., Sambrook P. N., Gwinn T. H. Somatomedin-C, physical fitness, and bone density. J Clin Endocrinol Metab. 1990 Mar;70(3):718–723. doi: 10.1210/jcem-70-3-718. [DOI] [PubMed] [Google Scholar]
  12. Labib M., Teale D., Marks V. Insulin-like growth factor 1 in patients with hypoglycaemia. Ann Clin Biochem. 1990 Mar;27(Pt 2):107–109. doi: 10.1177/000456329002700203. [DOI] [PubMed] [Google Scholar]
  13. Ljunghall S., Johansson A. G., Burman P., Kämpe O., Lindh E., Karlsson F. A. Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis. J Intern Med. 1992 Jul;232(1):59–64. doi: 10.1111/j.1365-2796.1992.tb00550.x. [DOI] [PubMed] [Google Scholar]
  14. Manolagas S. C., Jilka R. L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995 Feb 2;332(5):305–311. doi: 10.1056/NEJM199502023320506. [DOI] [PubMed] [Google Scholar]
  15. McAlindon T. E., Teale J. D., Dieppe P. A. Levels of insulin related growth factor 1 in osteoarthritis of the knee. Ann Rheum Dis. 1993 Mar;52(3):229–231. doi: 10.1136/ard.52.3.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McCloskey E. V., Spector T. D., Eyres K. S., Fern E. D., O'Rourke N., Vasikaran S., Kanis J. A. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int. 1993 May;3(3):138–147. doi: 10.1007/BF01623275. [DOI] [PubMed] [Google Scholar]
  17. Middleton J. F., Tyler J. A. Upregulation of insulin-like growth factor I gene expression in the lesions of osteoarthritic human articular cartilage. Ann Rheum Dis. 1992 Apr;51(4):440–447. doi: 10.1136/ard.51.4.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pun K. K., Lau P., Wong F. H., Cheng C. L., Pun W. K., Chow S. P., Leong J. C. 25-Hydroxycholecalciferol and insulin-like growth factor I are determinants of serum concentration of osteocalcin in elderly subjects with and without spinal fractures. Bone. 1990;11(6):397–400. doi: 10.1016/8756-3282(90)90133-j. [DOI] [PubMed] [Google Scholar]
  19. Reed B. Y., Zerwekh J. E., Sakhaee K., Breslau N. A., Gottschalk F., Pak C. Y. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res. 1995 Aug;10(8):1218–1224. doi: 10.1002/jbmr.5650100812. [DOI] [PubMed] [Google Scholar]
  20. Rudman D., Kutner M. H., Rogers C. M., Lubin M. F., Fleming G. A., Bain R. P. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest. 1981 May;67(5):1361–1369. doi: 10.1172/JCI110164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schouten J. S., Van den Ouweland F. A., Valkenburg H. A., Lamberts S. W. Insulin-like growth factor-1: a prognostic factor of knee osteoarthritis. Br J Rheumatol. 1993 Apr;32(4):274–280. doi: 10.1093/rheumatology/32.4.274. [DOI] [PubMed] [Google Scholar]
  22. Shimasaki S., Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res. 1991;3(4):243–266. doi: 10.1016/0955-2235(91)90003-m. [DOI] [PubMed] [Google Scholar]
  23. Spector T. D., Hart D. J., Byrne J., Harris P. A., Dacre J. E., Doyle D. V. Definition of osteoarthritis of the knee for epidemiological studies. Ann Rheum Dis. 1993 Nov;52(11):790–794. doi: 10.1136/ard.52.11.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Spector T. D., McCloskey E. V., Doyle D. V., Kanis J. A. Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study. J Bone Miner Res. 1993 Jul;8(7):817–822. doi: 10.1002/jbmr.5650080707. [DOI] [PubMed] [Google Scholar]
  25. Spector T. D. The fat on the joint: osteoarthritis and obesity. J Rheumatol. 1990 Mar;17(3):283–284. [PubMed] [Google Scholar]
  26. Wüster C., Blum W. F., Schlemilch S., Ranke M. B., Ziegler R. Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med. 1993 Sep;234(3):249–255. doi: 10.1111/j.1365-2796.1993.tb00740.x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES